Dichotomous roles of ACBD3 in NSCLC growth and metastasis

Xiaochao Tan1, Chao Wu2, Priyam Banerjee2,3

  • 1Department of Medicine, Tulane University School of Medicine, Louisiana Cancer Research Center, New Orleans, LA, USA. xtan4@tulane.edu.

Oncogene
|April 6, 2025
PubMed

Insights

Acyl-CoA binding domain containing 3 (ACBD3) protein promotes lung cancer growth in amplified cells but suppresses metastasis in diploid cells, revealing context-dependent gene roles in cancer progression.

Area of Science:

  • Molecular oncology
  • Cancer biology
  • Cell signaling

Background:

  • Lung cancer remains a leading global cause of cancer mortality.
  • Understanding gene function in cancer is critical for developing targeted therapies.
  • Gene roles can be context-dependent, complicating therapeutic strategies.

Purpose of the Study:

  • To investigate the dual role of acyl-CoA binding domain containing 3 (ACBD3) in lung cancer.
  • To elucidate the mechanisms by which ACBD3 influences lung cancer growth and metastasis.

Main Methods:

  • Investigated ACBD3 function in chromosome 1q-amplified and 1q-diploid lung cancer cells.
  • Examined ACBD3's interaction with phosphatidylinositol (PI)-4-kinase IIIβ (PI4KB) at the Golgi.
  • Assessed the impact of ACBD3 on oncogenic secretion and NOTCH signaling pathway activity.

Main Results:

  • ACBD3 promotes primary lung cancer growth in 1q-amplified cells by recruiting PI4KB to the Golgi, enhancing oncogenic secretion.
  • ACBD3 suppresses lung cancer metastasis in 1q-diploid cells by inhibiting the NOTCH pathway and reducing cell motility.
  • Demonstrates context-specific functions of ACBD3 in lung cancer progression.

Conclusions:

  • ACBD3 exhibits opposing roles in lung cancer growth and metastasis based on chromosome 1q copy number.
  • The findings highlight the complexity of cancer biology and the need for nuanced therapeutic approaches.
  • Context-dependent gene functions necessitate personalized strategies for lung cancer treatment.